|
Index of reports
> Life Threatening Events (89)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ribavirin life threatening events. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 89 Next >>
Possible Ribavirin side effects in 67 year old male
Reported by a pharmacist from United States on 2012-08-24
Patient: 67 year old male
Reactions: Drug Level Below Therapeutic, Anaemia, Deep Vein Thrombosis, Haematoma
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Telaprevir
Dosage: 750mg, tid, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-06-05
Ribavirin
Dosage: 600 mg, bid, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-02
End date: 2012-06-05
Possible Ribavirin side effects in
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-08-22
Patient:
Reactions: Pulmonary Embolism, Suicide Attempt, Depression, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
Ribavirin
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
PEG-Intron
Dosage: 120 micrograms, qw
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-02-11
End date: 2011-01-06
Placebo
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2010-03-11
End date: 2011-01-07
Blinded Boceprevir
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
Peginterferon Alfa-2B
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2010-03-11
End date: 2011-01-07
Rebetol
Dosage: 600 mg, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-02-11
End date: 2011-01-07
Other drugs received by patient: Norvir; Zolpidem Tatrate; Reyataz; Xanax; Escitalopram Oxalate; Epivir; Imodium; Invirase
Possible Ribavirin side effects in 68 year old female
Reported by a pharmacist from United States on 2012-08-20
Patient: 68 year old female
Reactions: Anaemia, Cough
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ribavirin
Possible Ribavirin side effects in male
Reported by a physician from United States on 2012-08-17
Patient: male, weighing 65.4 kg (143.8 pounds)
Reactions: Renal Failure
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Incivek
Indication: Hepatitis C
Start date: 2012-07-13
End date: 2012-07-19
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-13
End date: 2012-07-19
Pegasys
Indication: Hepatitis C
Start date: 2012-07-13
End date: 2012-07-19
Other drugs received by patient: Zantac; Lisinopril; Ramipril
Possible Ribavirin side effects in
Reported by a individual with unspecified qualification from Korea, Republic of on 2012-08-15
Patient:
Reactions: Major Depression
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Boceprevir
Dosage: 12 df, tid
Administration route: Oral
Start date: 2012-05-03
End date: 2012-05-30
Boceprevir
Dosage: 12 df, tid
Administration route: Oral
Start date: 2012-05-03
End date: 2012-05-30
Ribavirin
Dosage: 5 df, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-05
End date: 2012-05-30
Boceprevir
Dosage: 12 df, tid
Administration route: Oral
Start date: 2012-05-03
End date: 2012-05-30
Boceprevir
Dosage: 12 df, tid
Administration route: Oral
Start date: 2012-05-03
End date: 2012-05-30
PEG-Intron
Dosage: 1 df, qw
Indication: Hepatitis C
Start date: 2012-04-05
End date: 2012-05-30
Ribavirin
Dosage: 5 df, bid
Administration route: Oral
Start date: 2012-04-05
End date: 2012-05-30
Possible Ribavirin side effects in female
Reported by a pharmacist from United States on 2012-08-08
Patient: female, weighing 149.7 kg (329.3 pounds)
Reactions: Myocardial Infarction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: 600mg bid po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-23
End date: 2012-07-14
Pegasys
Dosage: 180mcg weekly sq
Indication: Hepatitis C
Start date: 2012-06-23
End date: 2012-07-14
Possible Ribavirin side effects in male
Reported by a individual with unspecified qualification from United States on 2012-08-08
Patient: male, weighing 148.0 kg (325.6 pounds)
Reactions: Chromatopsia, Loss of Consciousness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Incivek
Dosage: 2 tablets 3 times a day 7 to 9 hours apart
Indication: HIV Infection
Ribavirin
Dosage: twice a day
Indication: HIV Infection
End date: 2012-03-12
Pegasys
Dosage: 1 a week
Indication: Hepatitis C
Start date: 2012-01-12
Possible Ribavirin side effects in
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-02
Patient:
Reactions: Confusional State, Anaemia, Ketoacidosis, Ascites, Loss of Consciousness, Haemoglobin Decreased, Multi-Organ Failure, Renal Failure, Platelet Count Decreased, Septic Shock, Blood Glucose Increased
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2012-03-13
Victrelis
Dosage: 800 mg, q8h
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-05
End date: 2012-03-13
Pegasys
Dosage: 180 ?g, qw
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2012-03-13
Other drugs received by patient: Glyburide; Metformin Hydrochloride; Eprex; Nadolol; Diazepam; Spironolactone; Lasix
Possible Ribavirin side effects in female
Reported by a individual with unspecified qualification from United States on 2012-07-19
Patient: female, weighing 56.7 kg (124.7 pounds)
Reactions: Adverse Event
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-09-03
End date: 2012-05-13
Pegasys
Indication: Disease Recurrence
Start date: 2011-09-03
End date: 2012-05-13
Incivek
Dosage: 2 tablets 7-9 hrs apart
Victrelis
Dosage: 12 a day
Ribavirin
Dosage: (6) a day
Possible Ribavirin side effects in male
Reported by a pharmacist from United States on 2012-07-17
Patient: male, weighing 116.0 kg (255.2 pounds)
Reactions: Homicidal Ideation, Suicidal Ideation
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Ribavirin
Dosage: 600mg bid po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-12
End date: 2012-07-01
Pegasys
Dosage: 180 mcg weekly sq
Start date: 2012-01-12
End date: 2012-07-01
Other drugs received by patient: Aspirin; Temazepam; Percocet; Incivek; Xanax
Possible Ribavirin side effects in male
Reported by a pharmacist from United States on 2012-07-17
Patient: male, weighing 129.3 kg (284.4 pounds)
Reactions: Dehydration, Depression, Treatment Noncompliance, Suicidal Ideation, Influenza Like Illness
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Pegasys
Dosage: 180 mcg every week sq
Indication: Hepatitis C
Start date: 2011-10-03
End date: 2011-11-28
Ribavirin
Dosage: 600mg qam + pm every day po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-03
End date: 2011-11-28
Other drugs received by patient: Vitamin B Complex CAP; Methadone Hydrochloride; Metformin Hydrochloride; Prilosec; Prozac; Fish OIL; Multi-Vitamin; Incivek; Lyrica; Lisinopril and Hydrochlorothiazide; Xanax; Vitamin B-12; Vistaril; Glyburide
Possible Ribavirin side effects in 49 year old female
Reported by a physician from United States on 2012-07-03
Patient: 49 year old female
Reactions: Intentional Overdose, Suicide Attempt
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: 600 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Pegasys
Dosage: 180 mcg;qw;sc
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-28
End date: 2012-02-20
Victrelis
Dosage: 800 mg;q8h;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Tylenol
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Celexa; Remeron
Possible Ribavirin side effects in 37 year old female
Reported by a physician from Brazil on 2012-07-03
Patient: 37 year old female, weighing 66.3 kg (145.9 pounds)
Reactions: Anaemia, Pancytopenia, Fibromyalgia, Apparent Life Threatening Event, Depression, Acute Respiratory Failure, Septic Shock, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: 500 mg;q12h;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-16
End date: 2012-05-27
Victrelis
Dosage: 800 mcg;q8h;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-05-27
PEG-Intron
Dosage: 80 mcg;qw;sc
Indication: Hepatitis C
Start date: 2012-03-16
End date: 2012-05-27
Other drugs received by patient: Clonazepam; Sertraline Hydrochloride
Possible Ribavirin side effects in 60 year old male
Reported by a pharmacist from United States on 2012-06-26
Patient: 60 year old male
Reactions: Angioedema
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Ribavirin
Dosage: 500 mg;bid;
Indication: Hepatitis C
Victrelis
Dosage: 800 mg;q8h; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-04
Pegasys
Dosage: 180 mcg;qw;
Indication: Hepatitis C
Other drugs received by patient: Acetaminophen; Lactulose; Hydrochlorothiazide; Lisinopril
Possible Ribavirin side effects in 53 year old male
Reported by a pharmacist from Canada on 2012-06-26
Patient: 53 year old male, weighing 63.6 kg (139.8 pounds)
Reactions: Speech Disorder, Haemorrhage Intracranial, Gait Disturbance, Hemiplegia
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Ribavirin
Indication: Product Used FOR Unknown Indication
Possible Ribavirin side effects in 39 year old female
Reported by a physician from Spain on 2012-06-25
Patient: 39 year old female
Reactions: Anaemia, Hyponatraemia, Pulmonary Haemorrhage, Renal Failure, NO Therapeutic Response, Oedema, Thrombocytopenia, Asthenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: 1200 mg;qd; 800 mg;qd;
Indication: Hepatitis C
Start date: 2012-03-19
End date: 2012-04-30
Ribavirin
Dosage: 1200 mg;qd; 800 mg;qd;
Indication: Hepatitis C
Start date: 2012-04-30
End date: 2012-05-19
Victrelis
Dosage: 800 mg;q8h;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-05-28
Pegasys
Dosage: 180 mcg;qw; 135 mcg;qw;
Indication: Hepatitis C
Start date: 2012-03-19
End date: 2012-05-04
Pegasys
Dosage: 180 mcg;qw; 135 mcg;qw;
Indication: Hepatitis C
Start date: 2012-05-04
End date: 2012-05-18
Other drugs received by patient: Escitalopram; Acetaminophen; Lorazepam; Omeprazole
Possible Ribavirin side effects in female
Reported by a physician from United Kingdom on 2012-06-22
Patient: female
Reactions: Headache, Hypertension
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Blinded NO Treatment Received
Dosage: double blinded
Indication: Hepatitis C
Start date: 2011-10-31
Placebo
Dosage: double blinded
Indication: Hepatitis C
Start date: 2011-10-31
Pegasys
Dosage: 180 ug, qw
Indication: Hepatitis C
Start date: 2011-10-31
Omeprazole
Administration route: Oral
Indication: Gastrooesophageal Reflux Disease
Blinded Deb025
Dosage: double blinded
Indication: Hepatitis C
Start date: 2011-10-31
Ribavirin
Dosage: 600 mg, bid
Indication: Hepatitis C
Start date: 2011-10-31
Lansoprazole
Dosage: 30 mg, qd
Indication: Gastrooesophageal Reflux Disease
Start date: 2001-10-20
Possible Ribavirin side effects in 52 year old female
Reported by a individual with unspecified qualification from Poland on 2012-06-19
Patient: 52 year old female
Reactions: Agranulocytosis, Drug Ineffective, Hyperthyroidism
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: dose reduced
Peginterferon Alfa-2B
Indication: Hepatitis C
Ribavirin
Indication: Hepatitis C
Methimazole
Indication: Hyperthyroidism
Possible Ribavirin side effects in 51 year old male
Reported by a physician from Austria on 2012-06-19
Patient: 51 year old male, weighing 90.0 kg (198.0 pounds)
Reactions: Syncope, Brain Abscess, Epilepsy
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 mcg;qw;sc
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-09
Ribavirin
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-09
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Hepatitis C
End date: 2012-06-15
Possible Ribavirin side effects in female
Reported by a physician from United States on 2012-06-12
Patient: female
Reactions: Overdose, Suicide Attempt
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Victrelis
Indication: Product Used FOR Unknown Indication
Acetaminophen
Indication: Product Used FOR Unknown Indication
Ribavirin
Indication: Product Used FOR Unknown Indication
PEG-Intron
Indication: Product Used FOR Unknown Indication
Possible Ribavirin side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-08
Patient: female
Reactions: Thrombocytopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Ribavirin
Possible Ribavirin side effects in female
Reported by a pharmacist from United States on 2012-06-01
Patient: female, weighing 108.9 kg (239.5 pounds)
Reactions: Suicidal Ideation
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Ribavirin
Dosage: 400mg bid po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-14
End date: 2012-05-31
PEG-Intron
Dosage: 150mcg once weekly sq
Indication: Hepatitis C
Start date: 2012-03-14
End date: 2012-05-31
Possible Ribavirin side effects in 51 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-30
Patient: 51 year old female
Reactions: Diabetes Mellitus Inadequate Control
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Victrelis
Dosage: 800 mg;q8h;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-04-01
Pegasys
Dosage: 180 mcg;qw;
Indication: Product Used FOR Unknown Indication
Ribavirin
Dosage: 600 mg;bid;
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-01
Other drugs received by patient: Insulin
Possible Ribavirin side effects in 60 year old male
Reported by a physician from Portugal on 2012-05-29
Patient: 60 year old male
Reactions: Hepatic Neoplasm Malignant
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 100 mcg;qw;sc
Indication: Hepatitis C
Boceprevir (Sch-503034) (800 MG)
Dosage: 800 mg;q12h;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-01
End date: 2012-04-24
Ribavirin
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Other drugs received by patient: Vitamin B Complex / 00003501 /; Folic Acid
Possible Ribavirin side effects in female
Reported by a physician from United States on 2012-05-14
Patient: female, weighing 78.1 kg (171.8 pounds)
Reactions: Blood Iron Decreased, Vomiting, Skin Exfoliation, Nausea, Anaemia, DRY Skin, Fatigue, Dehydration, Depression, Asthenia, Decreased Appetite, Renal Failure Acute
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-27
End date: 2011-11-22
Pegasys
Indication: Hepatitis C
Start date: 2011-08-27
End date: 2011-11-22
Telaprevir
Dosage: 2 tablets
Indication: Hepatitis C
Start date: 2011-08-27
End date: 2011-11-22
Other drugs received by patient: Metformin HCL
Possible Ribavirin side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-09
Patient: 59 year old male
Reactions: Anaemia, Ketoacidosis, Ascites, Loss of Consciousness, Multi-Organ Failure, Renal Failure, Platelet Count Decreased, Septic Shock, Blood Glucose Increased
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Victrelis
Dosage: 800 mg;q8h;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-05
End date: 2012-03-13
Pegasys
Dosage: 180 mcg;qw;sc
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2012-03-13
Ribavirin
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2012-03-13
Other drugs received by patient: Glyburide; Eprex; Nadol; Metformin HCL; Diazepam; Lasix
Possible Ribavirin side effects in 50 year old female
Reported by a physician from United States on 2012-05-08
Patient: 50 year old female
Reactions: Diabetes Mellitus Inadequate Control
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 200 mg;qid;po
Administration route: Oral
Indication: Hepatitis C
Ribavirin
Indication: Product Used FOR Unknown Indication
Possible Ribavirin side effects in 79 year old male
Reported by a physician from France on 2012-05-08
Patient: 79 year old male, weighing 60.0 kg (132.0 pounds)
Reactions: Hyperglycaemia, Hypertension, Fall, Cerebral Haemorrhage
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Viraferonpeg
Dosage: 0.5 mcg/ kg; qw;
Indication: Hepatitis C
Start date: 2008-01-16
End date: 2008-07-26
Ribavirin
Dosage: 800 mg; qd;
Indication: Hepatitis C
Start date: 2008-01-16
End date: 2008-07-26
Other drugs received by patient: Lantus; Diamicron; Exforge; Metformin HCL; Glucor 50
Possible Ribavirin side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-08
Patient: 56 year old male, weighing 49.0 kg (107.8 pounds)
Reactions: Multi-Organ Failure, Rhabdomyolysis, Lactic Acidosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Peginterferon Alfa-2A
Indication: Hepatitis C
Start date: 2012-01-24
End date: 2012-04-10
Janumet
Administration route: Oral
Indication: Type 2 Diabetes Mellitus
End date: 2012-04-10
Telaprevir
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-24
End date: 2012-04-10
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-24
End date: 2012-04-10
Other drugs received by patient: Epoetin Beta
Possible Ribavirin side effects in 60 year old male
Reported by a physician from Portugal on 2012-05-03
Patient: 60 year old male
Reactions: Hepatic Neoplasm Malignant
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Ribavirin
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Boceprevir (Sch-503034) (800 MG)
Dosage: 800 mg;q12h;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Peginterferon Alfa-2B
Dosage: 100 mcg;qw;sc
Indication: Product Used FOR Unknown Indication
Page 1 Next >>
|
